Literature DB >> 15559483

Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study.

Fiona Dallas1, Sarah B Jenkins, Martin E Wilkie.   

Abstract

OBJECTIVE: A pilot study to compare the use of a combination dialysate (7.5% icodextrin/1.36% glucose) versus icodextrin 7.5% alone for the long dwell in patients on peritoneal dialysis (PD).
DESIGN: A 4-week, prospective, randomized crossover study.
SETTING: A large regional renal unit providing treatment for a population of 1.7 million. PATIENTS: Five patients on continuous ambulatory PD (CAPD) and 3 patients on automated PD. MAIN OUTCOME MEASUREMENTS: Long-dwell and 24-hour ultrafiltration volumes, body weight, 24-hour ambulatory blood pressure, and antihypertensive/diuretic tablet count.
RESULTS: The use of the combination dialysate resulted in an increase in the median (interquartile range) long-dwell ultrafiltration, from 750 (650-828) mL to 1000 (889-1100) mL (p < 0.001), and 24-hour ultrafiltration, from 739 (400-1623) mL to 956 (700-1750) mL (p < 0.001). Weight, blood pressure, and tablet count remained unchanged.
CONCLUSIONS: The use of the novel combination dialysate resulted in a 33% increase in long-dwell ultrafiltration and a 29% increase in 24-hour ultrafiltration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15559483

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  5 in total

1.  Mechanisms of Crystalloid versus Colloid Osmosis across the Peritoneal Membrane.

Authors:  Johann Morelle; Amadou Sow; Charles-André Fustin; Catherine Fillée; Elvia Garcia-Lopez; Bengt Lindholm; Eric Goffin; Fréderic Vandemaele; Bengt Rippe; Carl M Öberg; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2018-05-29       Impact factor: 10.121

2.  A patient with refractory nephrotic syndrome withdrawn from peritoneal dialysis.

Authors:  Satoshi Morimoto; Nobuyuki Takahashi; Kazunori Someya; Tatsuyori Morita; Fusakazu Jo; Nagaoki Toyoda; Atsushi Kosaki; Mitsushige Nishikawa; Toshiji Iwasaka
Journal:  Clin Exp Nephrol       Date:  2010-02-26       Impact factor: 2.801

Review 3.  Icodextrin and peritoneal dialysis: advantages and new applications.

Authors:  Periklis Dousdampanis; Carlos Guido Musso; Konstantina Trigka
Journal:  Int Urol Nephrol       Date:  2017-07-03       Impact factor: 2.370

4.  Bimodal solutions or twice-daily icodextrin to enhance ultrafiltration in peritoneal dialysis patients.

Authors:  Periklis Dousdampanis; Konstantina Trigka; Joanne M Bargman
Journal:  Int J Nephrol       Date:  2013-01-08

5.  Biocompatible dialysis fluids for peritoneal dialysis.

Authors:  Htay Htay; David W Johnson; Kathryn J Wiggins; Sunil V Badve; Jonathan C Craig; Giovanni Fm Strippoli; Yeoungjee Cho
Journal:  Cochrane Database Syst Rev       Date:  2018-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.